register

News & Trends - Pharmaceuticals

Health Minister commits millions to bushfire research

Health Industry Hub | January 20, 2020 |

Health Minister, Greg Hunt, announced $5 million funding for research into the biological, psychological and behavioural impacts of prolonged exposure to bushfire smoke on people and communities.

AMA President, Dr Tony Bartone, said that the findings will provide people with better knowledge of prevention measures and empower doctors with better clinical solutions to care for communities affected by future extreme bushfires.

The announcement follows weeks of warnings in the media about air quality and the effects on human health from Dr Bartone and other AMA spokespeople.

Dr Bartone said that the short-term effects of hazardous air quality are well-researched, but the long-term effects of short and medium time periods of exposure are not well understood.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

“The AMA has been extensively engaged in responding to both our patients and the wider public’s concerns about the impact of hazardous air on individual and population health over the last couple of months,” Dr Bartone said.

“General practitioners are treating people in fire-ravaged areas and other communities, and seeing first-hand those affected by the physical conditions and mental health consequences of ongoing exposure to hazardous air.

“However, the lack of clinical and public health research evidence about the long-term impacts of the kind of exposure to hazardous air we have seen in the last few months makes public education challenging.

“We need to rapidly translate the research findings into everyday medical practice to facilitate comprehensive care and treatment and improve health literacy,” Dr Bartone said.

Enhance your business visibility, optimise reach and differentiate your brand. Health Industry Hub is the only one-stop-hub connecting your business to Australia’s Pharma, MedTech, and Biotech industry professionals. Get started with our unique media solutions.

The grant round will open Friday, 17 January 2020 and closes Friday, 31 January 2020.

For further details about this MRFF announcement visit https://www.grants.gov.au/

Details relating to the Australian Governments comprehensive response to the bushfire disaster can be located at https://www.pm.gov.au/media/national-bushfire-recovery-agency

You may also like Celgene backs out of $55M class action settlement


News & Trends - Biotechnology

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

AusBiotech appoints new CEO: Former Sanofi corporate affairs and sustainability leader takes the helm

Health Industry Hub | April 23, 2024 |

Biotech News: AusBiotech, the nation’s leading industry body for the biotech sector, has named former leader at Sanofi, Rebekah Cassidy, […]

More


News & Trends - MedTech & Diagnostics

Federal government invests in Siemens Healthineers scanner to 'reduce wait times' for cancer diagnosis

Federal government invests in Siemens Healthineers scanner to ‘reduce wait times’ for cancer diagnosis

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: The Albanese Government is investing $12 million through the 2024–25 Budget, to purchase and install a […]

More


News & Trends - MedTech & Diagnostics

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Cardiac device benefits face more cuts, while technical services remain secure in the short term

Health Industry Hub | April 23, 2024 |

MedTech & Diagnostics News: Starting from July 2024, Cardiac Implantable Electronic Devices (CIED) listed on the Prescribed List (PL) will […]

More


News & Trends - Biotechnology

CSL's world-first gene therapy heads for MSAC assessment

CSL’s world-first gene therapy heads for MSAC evaluation

Health Industry Hub | April 23, 2024 |

Biotech News: CSL’s world-first gene therapy for haemophilia B is scheduled for consideration at the upcoming Medical Services Advisory Committee (MSAC) […]

More


This content is copyright protected. Please subscribe to gain access.